Organogenesis Holdings Stock Investor Sentiment
| ORGO Stock | USD 4.97 0.04 0.80% |
About 57% of all Organogenesis Holdings' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Organogenesis Holdings suggests that some traders are interested. Organogenesis Holdings' investing sentiment overview a quick insight into current market opportunities from investing in Organogenesis Holdings. Many technical investors use Organogenesis Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Organogenesis |
Organogenesis Holdings Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Organogenesis Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Organogenesis Holdings that are available to investors today. That information is available publicly through Organogenesis media outlets and privately through word of mouth or via Organogenesis internal channels. However, regardless of the origin, that massive amount of Organogenesis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Organogenesis Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Organogenesis Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Organogenesis Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Organogenesis Holdings alpha.
Organogenesis Holdings Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 5585 shares by Gillheeney Gary S. of Organogenesis Holdings at 3.49 subject to Rule 16b-3 | 12/16/2024 |
2 | Disposition of 500000 shares by Gn 2016 Family Trust Uad August 12, 2016 of Organogenesis Holdings at 4.057 subject to Rule 16b-3 | 12/27/2024 |
3 | Acquisition by Ades Alan A. of 6401945 shares of Organogenesis Holdings subject to Rule 16b-3 | 01/08/2025 |
4 | Disposition of 3643 shares by Freedman Lori of Organogenesis Holdings at 3.68 subject to Rule 16b-3 | 01/17/2025 |
5 | Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on ... | 01/27/2025 |
6 | Disposition of 17972 shares by Erani Albert of Organogenesis Holdings at 4.2775 subject to Rule 16b-3 | 01/28/2025 |
7 | Disposition of 804 shares by David Francisco of Organogenesis Holdings at 3.7 subject to Rule 16b-3 | 02/14/2025 |
8 | Acquisition by Driscoll Michael Joseph of 49575 shares of Organogenesis Holdings subject to Rule 16b-3 | 02/19/2025 |
9 | What To Expect From Organogenesis Holdings Inc Q4 2024 Earnings | 02/26/2025 |
10 | Organogenesis Holdings Inc Q4 2024 Earnings EPS of 0. ... | 02/27/2025 |
11 | Q4 2024 Organogenesis Holdings Inc Earnings Call Transcript | 02/28/2025 |
12 | Disposition of 25000 shares by Driscoll Michael Joseph of Organogenesis Holdings at 5.1014 subject to Rule 16b-3 | 03/04/2025 |
13 | Organogenesis Shares Down 6.2 percent Heres What Happened | 03/05/2025 |
14 | Insider Sell Michael Driscoll Sells 25,000 Shares of Organogenesis Holdings Inc | 03/07/2025 |
15 | Disposition of 8657 shares by Montecalvo Antonio S. of Organogenesis Holdings at 3.7 subject to Rule 16b-3 | 03/14/2025 |
Check out Organogenesis Holdings Hype Analysis, Organogenesis Holdings Correlation and Organogenesis Holdings Performance. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.5 | Earnings Share (0.01) | Revenue Per Share | Quarterly Revenue Growth 0.271 | Return On Assets |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.